Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

Research output: Contribution to journalLetterpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{8d30caaea00b498cb5580b42cec3ce37,
title = "Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study",
keywords = "perianal fistulizing Crohn disease, ustekinumab",
author = "Mohamed Attauabi and Johan Burisch and Seidelin, {Jakob Benedict}",
note = "Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = mar,
doi = "10.1093/ibd/izaa297",
language = "English",
volume = "27",
pages = "e37--e38",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John/Wiley & Sons, Inc",
number = "3",

}

RIS

TY - JOUR

T1 - Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease

T2 - A Double-Center Cohort Study

AU - Attauabi, Mohamed

AU - Burisch, Johan

AU - Seidelin, Jakob Benedict

N1 - Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3

Y1 - 2021/3

KW - perianal fistulizing Crohn disease

KW - ustekinumab

UR - http://www.scopus.com/inward/record.url?scp=85097191469&partnerID=8YFLogxK

U2 - 10.1093/ibd/izaa297

DO - 10.1093/ibd/izaa297

M3 - Letter

C2 - 33200769

VL - 27

SP - e37-e38

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 3

ER -

ID: 61288376